Treatment characteristics and inherent prostatic features do not predict patient outcome after high-energy transurethral thermotherapy: A prospective study of ProstaLund Feedback Treatment™

Journal of Endourology

Volumn 20, Issue 12, 2006, Pages 1075-1081

  Ferakis, N ^a   Skolarikos, A ^a   Staios, D ^a   Liakouras, C ^a   Alivizatos, Gerasimos ^a,b  

^a UNIVERSITY OF ATHENS   (Greece)

^b Dept of Urology ^*  (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; BLADDER NECK STENOSIS; CLINICAL ARTICLE; DEVICE; ENERGY CONSUMPTION; HIGH ENERGY TRANSURETHRAL THERMOTHERAPY; HUMAN; HYPERTHERMIC THERAPY; INDWELLING CATHETER; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOGISTIC REGRESSION ANALYSIS; MALE; ORGAN WEIGHT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE; QUALITY OF LIFE; RESIDUAL URINE; SCORING SYSTEM; TEMPERATURE; TISSUE NECROSIS; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 33846141154     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2006.20.1075     Document Type: Article

References (24)

1. Wagrell L, Schelin S, Nordling J, et al. Three-year follow-up of feedback microwave thermotherapy versus TURP for clinical BPH: A prospective randomized multicenter study. Urology 2004;64:698.
2. Walmsley K, Kaplan S. Transurethral microwave thermotherapy for benign prostate hyperplasia: Separating truth from marketing hype. J Urol 2004;172:1249.
3. Eliasson TU, Abramsson LB, Pettersson GT, et al. Responders and non-responders to treatment of benign prostatic hyperplasia with transurethral microwave thermotherapy. Scand J Urol Nephrol 1995;29:183.
4. Hallin A, Berlin T. Transurethral microwave thermotherapy of benign prostatic hyperplasia: Do any pretreatment conditions predict the results? Eur Urol 1996;30:429.
5. Rosette JJ de la, Wildt MJ de, Hofner K, et al. High energy thermotherapy in the treatment of benign prostatic hyperplasia: Results of the European Benign Prostatic Hyperplasia Study Group. J Urol 1996;156:97.
6. Walden M, Dahlstrand C, Schafer W, et al. How to select patients suitable for transurethral microwave thermotherapy: A systematic evaluation of potentially predictive variables. Br J Urol 1998;81:817.
7. d'Ancona FCH, Francisca EAE, Hendriks JCM, et al. How to select patients for high energy transurethral microwave thermotherapy? Urology 1999;55:111.
8. Terada N, Aoki Y, Ichioka K, et al. Microwave thermotherapy for benign prostatic hyperplasia with the Dornier Urowave: Response durability and variables potentially predicting response. Urology 2001;57:701.
9. Laguna MP, Kiemeney LA, Debruyne FMJ, et al. Baseline prostatic specific antigen does not predict the outcome of high energy transurethral microwave thermotherapy. J Urol 2002;167:1727.
10. Alivizatos G, Ferakis N, Mitropoulos D, et al. Feedback microwave thermotherapy with the ProstaLund® Compact device for obstructive benign prostatic hyperplasia: 12-month response rates and complications. J Endourol 2005;19:72.
11. Pennes HH. Analysis of tissue and arterial blood temperatures in the resting human forearm. J Appl Physiol 1948;1:93.
12. Henriques FC. Studies of thermal injury. Arch Pathol 1947;43:489.
13. Djavan B, Seitz C, Ghawidel K, et al. High-energy transurethral microwave thermotherapy in patients with acute urinary retention due to benign prostatic hyperplasia. Urology 1999;54:18.
14. Floratos D, Sonke G, Francisca E, et al. High energy transurethral microwave thermotherapy for the treatment of patients in urinary retention. J Urol 2000;163:1457.
15. Schelin S. Microwave thermotherapy in patients with benign prostatic hyperplasia and chronic urinary retention. Eur Urol 2001;39:400.
16. Bolmsjo M, Sturesson C, Wagrell L, et al. Optimizing transurethral microwave thermotherapy: A model for studying power, blood flow, temperature variations and tissue destruction. Br J Urol 1998;81:811.
17. Bhowmick P, Coad JE, Bhowmick S, et al. In vitro assessment of the efficacy of thermal therapy in human benign prostatic hyperplasia. Int J Hyperthermia 2004;20:421.
18. Arai Y, Fukuzawa S, Terai A, et al. Transurethral microwave thermotherapy for benign prostatic hyperplasia: Relation between clinical response and prostate histology. Prostate 1996;28:84.
19. d'Ancona FC, Albers YH, Kiemeney LA, et al. Can histopathology predict treatment outcome following high-energy transurethral microwave thermotherapy of the prostate? Results of a biopsy study. Prostate 1999;40:28.
20. Roehrborn CG, Korngrad A, McConnel JD. Temperature mapping in the canine prostate during transurethrally-applied local microwave hyperthermia. Prostate 1992;20:97.
21. Hoffman A, Laguna P, Rosette JJ de la, et al. Quantification of prostate shrinkage after microwave thermotherapy: A comparison of calculated cell-kill versus 3D transrectal ultrasound planimetry. Eur Urol 2003;43:181.
22. Huidobro C, Bolmsjo M, Larson T, et al. Evaluation of microwave thermotherapy with histopathology, magnetic resonance imaging and temperature mapping. J Urol 2004;171:672.
23. Corvin S, Boesch S, Maneschg C, et al. Effect of heat exposure on viability and contractility of cultured prostatic stromal cells. Eur Urol 2000;37:499.
24. Larson B, Huidobro C, Acevedo C, et al. In-vivo temperature mapping of prostate during treatment with TherMatrx TMx-2000 device: Heat field and MRI determinations of necrotic lesions. J Endourol 2005;19:1021.